These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19734440)

  • 1. Does one size fit all? Investigating heterogeneity in men's preferences for benign prostatic hyperplasia treatment using mixed logit analysis.
    Eberth B; Watson V; Ryan M; Hughes J; Barnett G
    Med Decis Making; 2009; 29(6):707-15. PubMed ID: 19734440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Men's preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment.
    Mankowski C; Ikenwilo D; Heidenreich S; Ryan M; Nazir J; Newman C; Watson V
    Patient Prefer Adherence; 2016; 10():2407-2417. PubMed ID: 27920507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
    Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
    Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Watson V; Ryan M; Brown CT; Barnett G; Ellis BW; Emberton M
    J Urol; 2004 Dec; 172(6 Pt 1):2321-5. PubMed ID: 15538258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Best of Both Worlds: An Example Mixed Methods Approach to Understand Men's Preferences for the Treatment of Lower Urinary Tract Symptoms.
    Ikenwilo D; Heidenreich S; Ryan M; Mankowski C; Nazir J; Watson V
    Patient; 2018 Feb; 11(1):55-67. PubMed ID: 28660567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia With Severe Lower Urinary Tract Dysfunction With Combination of Dutasteride and Solifenacin.
    Kosilov K; Kuzina I; Kuznetsov V; Gainullina Y; Kosilova L; Karashchuk E; Prokofyeva A; Loparev S
    J Sex Med; 2018 Nov; 15(11):1579-1590. PubMed ID: 30415813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliciting men's preferences for decision-making relative to treatments of localized prostate cancer with a good or moderate prognosis.
    Lejeune C; Bourredjem A; Binquet C; Cussenot O; Boudrant G; Papillon F; Bruyère F; Haillot O; Koutlidis N; Bassard S; Fournier G; Valeri A; Moreau JL; Pierfitte B; Moulin M; Berchi C; Cormier L
    World J Urol; 2023 Jun; 41(6):1541-1549. PubMed ID: 37173454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Men's theories about benign prostatic hyperplasia and prostate cancer following a benign prostatic hyperplasia decision aid.
    Holmes-Rovner M; Price C; Rovner DR; Kelly-Blake K; Lillie J; Wills C; Bonham VL
    J Gen Intern Med; 2006 Jan; 21(1):56-60. PubMed ID: 16423124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
    Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
    J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study.
    Toren P; Margel D; Kulkarni G; Finelli A; Zlotta A; Fleshner N
    BMJ; 2013 Apr; 346():f2109. PubMed ID: 23587564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction.
    Emberton M
    Int J Clin Pract; 2010 Sep; 64(10):1425-35. PubMed ID: 20579137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Roehrborn CG; Manyak MJ; Palacios-Moreno JM; Wilson TH; Roos EPM; Santos JC; Karanastasis D; Plastino J; Giuliano F; Rosen RC
    BJU Int; 2018 Apr; 121(4):647-658. PubMed ID: 29044968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment preference patterns during a videotape decision aid for benign prostatic hyperplasia (BPH).
    Wills CE; Holmes-Rovner M; Rovner D; Lillie J; Kelly-Blake K; Bonham V; Williams G
    Patient Educ Couns; 2006 Apr; 61(1):16-22. PubMed ID: 16533674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?
    Stoevelaar HJ; Van de Beek C; Casparie AF; McDonnell J; Nijs HG
    J Urol; 1999 Jan; 161(1):133-8. PubMed ID: 10037385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic Therapy in Men's Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia.
    Berkseth KE; Thirumalai A; Amory JK
    Med Clin North Am; 2016 Jul; 100(4):791-805. PubMed ID: 27235615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia.
    Llewellyn-Thomas HA; Williams JI; Levy L; Naylor CD
    Med Decis Making; 1996; 16(3):262-82. PubMed ID: 8818125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.